Clinical trial NCT02203786 - References

Pathological Gambling — D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement

Citation(s)

•   APA (2000) Diagnostic and Statistical Manual of Mental Disorders
  IV-TR ed. American Psychiatric Association: Washington, DC.
•   Enggasser JL, de Wit H
  Haloperidol reduces stimulant and reinforcing effects of ethanol in social drinkers. Alcohol Clin Exp Res. 2001 Oct;25(10):1448-56.
•   Holley FO, Magliozzi JR, Stanski DR, Lombrozo L, Hollister LE
  Haloperidol kinetics after oral and intravenous doses. Clin Pharmacol Ther. 1983 Apr;33(4):477-84.
•   Lesieur HR, Blume SB
  The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry. 1987 Sep;144(9):1184-8.
•   Midha KK, McKay G, Edom R, Korchinski ED, Hawes EM, Hall K
  Kinetics of oral fluphenazine disposition in humans by GC-MS. Eur J Clin Pharmacol. 1983;25(5):709-11.
•   Wachtel SR, Ortengren A, de Wit H
  The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers. Drug Alcohol Depend. 2002 Sep 1;68(1):23-33.
•   Wong YN, Wang L, Hartman L, Simcoe D, Chen Y, Laughton W, Eldon R, Markland C, Grebow P
  Comparison of the single-dose pharmacokinetics and tolerability of modafinil and dextroamphetamine administered alone or in combination in healthy male volunteers. J Clin Pharmacol. 1998 Oct;38(10):971-8.

Comparative Effects of a D2 and Mixed D1-D2 Dopamine Antagonist on Gambling and Amphetamine Reinforcement in Pathological Gamblers and Healthy Controls

Details for clinical trial NCT02203786